BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Treatment
69 results:

  • 1. Vitamin C enhances co-localization of novel TET1 nuclear bodies with both Cajal and PML bodies in colorectal cancer cells.
    El Osmani N; Prévostel C; Picque Lasorsa L; El Harakeh M; Radwan Z; Mawlawi H; El Sabban M; Shirinian M; Dassouki Z
    Epigenetics; 2024 Dec; 19(1):2337142. PubMed ID: 38583183
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection.
    Hofmann S; Luther J; Plank V; Oswald A; Mai J; Simons I; Miller J; Falcone V; Hansen-Palmus L; Hengel H; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2024 May; 12(5):e0378823. PubMed ID: 38567974
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia.
    Jung HW; Kim CY; Hong SP; Bae HJ; Choi JY; Ryu JK; Lee JB; Lee KH; Han KR; Yang DH; Park CG; Yu GW; Rhee MY; Park SJ; Hyon MS; Shin JH; Hong BK; Jin HY; Lee SY; Seol SH; Lee SR; Kim SY; Lee KJ; Cho EJ; Nam CW; Park TH; Kim U; Kim KS
    J Clin Hypertens (Greenwich); 2023 Sep; 25(9):828-844. PubMed ID: 37584254
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Interplay between PML nbs and HIRA for H3.3 dynamics following type I interferon stimulus.
    Kleijwegt C; Bressac F; Seurre C; Bouchereau W; Cohen C; Texier P; Simonet T; Schaeffer L; Lomonte P; Corpet A
    Elife; 2023 May; 12():. PubMed ID: 37227756
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Phase separation is required for PML nuclear body biogenesis and function.
    Wu W; Tan Y; Yin H; Jiang M; Jiang Y; Ma X; Yin T; Li Y; Zhang H; Cai X; Meng G
    FASEB J; 2023 Jun; 37(6):e22986. PubMed ID: 37219517
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
    Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
    Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Crosstalk between PML and p53 in response to TGF-β1: A new mechanism of cardiac fibroblast activation.
    Huang D; Zhao D; Li M; Chang SY; Xue YD; Xu N; Li SJ; Tang NN; Gong LL; Liu YN; Yu H; Li QS; Li PY; Liu JL; Chen HX; Liu MB; Zhang WY; Zhao XM; Lang XZ; Li ZD; Liu Y; Ma ZY; Li JM; Wang N; Tian H; Cai BZ
    Int J Biol Sci; 2023; 19(3):994-1006. PubMed ID: 36778116
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. In silico comprehensive analysis of coding and non-coding SNPs in human mTOR protein.
    Yasmin T
    PLoS One; 2022; 17(7):e0270919. PubMed ID: 35788771
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies.
    Filipiuk A; Kozakiewicz A; Kośmider K; Lejman M; Zawitkowska J
    Ann Agric Environ Med; 2022 Jun; 29(2):207-214. PubMed ID: 35767752
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PML Nuclear Body Biogenesis, Carcinogenesis, and Targeted Therapy.
    Li Y; Ma X; Wu W; Chen Z; Meng G
    Trends Cancer; 2020 Oct; 6(10):889-906. PubMed ID: 32527650
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia.
    He X; Feng Z; Ma J; Ling S; Cao Y; Gurung B; Wu Y; Katona BW; O'Dwyer KP; Siegel DL; June CH; Hua X
    Blood; 2020 Mar; 135(10):713-723. PubMed ID: 31951650
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.
    Wang C; Su L; Shao YM; Chen WZ; Bu N; Hao R; Ma LY; Hussain L; Lu XY; Wang QQ; Naranmandura H
    Toxicol Appl Pharmacol; 2019 Dec; 384():114775. PubMed ID: 31669778
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Post-translational Modifications of PML in Regulating the Functions of Nuclear Bodies --Review].
    Ma XF; Tan Y; Li SF; Jin W; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1696-1700. PubMed ID: 31607334
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PML nuclear bodies are recruited to persistent DNA damage lesions in an RNF168-53BP1 dependent manner and contribute to DNA repair.
    Vancurova M; Hanzlikova H; Knoblochova L; Kosla J; Majera D; Mistrik M; Burdova K; Hodny Z; Bartek J
    DNA Repair (Amst); 2019 Jun; 78():114-127. PubMed ID: 31009828
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Involvement of PML proteins in treatment of acute promyelocytic leukemia with arsenic trioxide].
    Hao R; Su L; Shao Y; Bu N; Ma L; Naranmandura H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):541-551. PubMed ID: 30693698
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
    Urtishak KA; Wang LS; Culjkovic-Kraljacic B; Davenport JW; Porazzi P; Vincent TL; Teachey DT; Tasian SK; Moore JS; Seif AE; Jin S; Barrett JS; Robinson BW; Chen IL; Harvey RC; Carroll MP; Carroll AJ; Heerema NA; Devidas M; Dreyer ZE; Hilden JM; Hunger SP; Willman CL; Borden KLB; Felix CA
    Oncogene; 2019 Mar; 38(13):2241-2262. PubMed ID: 30478448
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.
    Liu D; Zhong L; Yuan Z; Yao J; Zhong P; Liu J; Yao S; Zhao Y; Liu L; Chen M; Li L; Liu B
    Cell Signal; 2019 Feb; 54():1-9. PubMed ID: 30453015
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells.
    Hirano S; Udagawa O; Kobayashi Y; Kato A
    Toxicol Appl Pharmacol; 2018 Dec; 360():150-159. PubMed ID: 30292834
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Acute promyelocytic leukemia: state-of-the-art management].
    Asou N
    Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.